Viewing Study NCT02900651


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-02-20 @ 9:51 AM
Study NCT ID: NCT02900651
Status: TERMINATED
Last Update Posted: 2025-08-11
First Post: 2016-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MAK683, DLBCL, EED - Embryonic ectoderm development, EZH2 - Enhancer … View